共 23 条
- [1] Easton J.D., Saver J.L., Albers G.W., Alberts M.J., Chaturvedi S., Feldmann E., Et al., Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/American stroke association stroke council
- [2] council on cardiovascular surgery and anesthesia
- [3] council on cardiovascular radiology and intervention
- [4] council on cardiovascular nursing
- [5] and the interdisciplinary council on peripheral vascular disease, Stroke, 40, pp. 2276-2293, (2009)
- [6] Petty G.W., Brown R.D., Whisnant J.P., Sicks J.D., Michael O., fallon W., Wiebers D.O., Ischemic Stroke Subtypes A Population-Based Study of Incidence and Risk Factors, (1999)
- [7] Hessels J., Kroon S., Vorselaars V.V.M., Boerman S., Mager J.J., Post M.C., Evolution of pulmonary arteriovenous malformations: the role of contrast echocardiography, Chest, 163, 3, pp. 669-677, (2023)
- [8] Shovlin C.L., Gibbs J.S.R., Jackson J.E., Management of pulmonary arteriovenous malformations in pulmonary hypertensive patients: a pressure to embolise?, Eur. Respir. Rev., 18, pp. 4-6, (2009)
- [9] Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E., Hyland R.H., Westermann C.J.J., Et al., Diagnostic criteria for hereditary hemorrhagic telangiectasia (rendu- osler-weber syndrome), Am. J. Med. Genet., 91, 1, pp. 66-67, (2000)
- [10] McDonald J., Bayrak-Toydemir P., DeMille D., Wooderchak-Donahue W., Whitehead K., Curaçao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2), Genet. Med., 22, 7, pp. 1201-1205, (2020)